))
Immunotherapy for Breast Cancer: Who Qualifies and How It’s Making a Difference
Manage episode 485683826 series 3660316
Content provided by DR. CHRISTINA NG VAN TZE. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by DR. CHRISTINA NG VAN TZE or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
In this episode, we explore how immunotherapy is changing breast cancer treatment, especially for patients with hard-to-treat forms like metastatic triple-negative breast cancer.
You’ll learn:
- What immunotherapy is and how it helps the immune system fight cancer
- The role of immune checkpoint inhibitors in treating breast cancer
- What does PD-L1 expression and MSI-H status mean for your treatment options
- How immunotherapy works at different stages of breast cancer
- Why it’s most effective for metastatic and PD-L1-positive tumors
- What side effects to expect and how doctors manage them
If you or a loved one is facing breast cancer, this episode breaks down who can benefit from immunotherapy—and how this treatment is offering new hope when other options fall short.
Blog Link: Immunotherapy for Breast Cancer: Who Can Benefit?
Thank you for listening to The Onco Life Podcast, your trusted source for expert cancer information and patient-centered education.
📍 Visit us at oncolifecentre.com
📞 Call: +603-2242-2620
📧 Book a consultation or ask a question — we're here to support your journey.
17 episodes
Share
